Company: PIII
Filing Date: 2025-02-13
Form Type: 8-K
Source: 0001628280-25-005308
Chunk: 0

Company: P3 Health Partners Inc.
Filing Date: 2025-02-13
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01 Regulation FD Disclosure.

On February 13, 2025, P3 Health Partners Inc. (the “ Company”) issued a press release announcing initial financial guidance and projected Medicare Advantage membership for the full fiscal year ending December 31, 2025 and a proposed financing transaction with its largest shareholder. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 7.01, including the information contained in Exhibit 99.1 of this Current Report on Form 8-K, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Cautionary Note RegardingForward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward-looking statements. These statements include, but are not limited to, statements regarding the Company’s financial and Medicare Advantage membership guidance for fiscal year 2025, the Company’s expected financial performance, and the proposed financing transaction with the Company’s largest shareholder and expected terms thereof. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “ Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission (“ SEC”), as updated by Part II, Item 1A. “ Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2024 and our other filings with the SEC. You are cautioned not to place undue reliance on any forward-looking statements made herein. Any forward-looking statement speaks only as of the